Business Insiderยท2025-09-23 22:21Core Viewpoint - Kenvue, the company behind Tylenol, is facing a crisis due to President Trump's comments regarding the safety of the drug, which echoes a historical crisis from the 1980s when Tylenol was involved in a poisoning scandal [1][2][3] Group 1: Historical Context - The original Tylenol crisis occurred in 1982 when seven people died after consuming capsules laced with potassium cyanide, leading to the "Tylenol murders" [1] - Johnson & Johnson (J&J), the original owner, effectively managed the crisis, setting a standard for crisis management that is still referenced today [1][3] - J&J's response included immediate public warnings, a consumer hotline, and a significant recall of millions of bottles, which accounted for 19% of J&J's corporate profits in the first three quarters of 1982 [14][13] Group 2: Current Crisis Management - In response to Trump's claims, Kenvue quickly issued a statement defending Tylenol, emphasizing that acetaminophen is safe for pregnant women and that there is no credible evidence linking it to autism [2][9] - Kenvue's rapid response contrasts with the slower communication methods of the 1980s, highlighting the importance of timely and focused messaging in today's fast-paced information environment [4][8] - Experts suggest that Kenvue should maintain a clear and consistent message to reassure the public about Tylenol's safety, similar to J&J's approach in the past [10][12][17] Group 3: Industry Impact and Future Outlook - J&J's handling of the 1982 crisis not only salvaged the Tylenol brand but also led to industry-wide changes, such as the introduction of tamper-proof seals on medication [15][16] - Experts believe that Kenvue can navigate the current situation successfully, as Tylenol has a long-standing reputation and has weathered past crises [17] - The company is advised to continue reinforcing its safety message and potentially engage in further studies to validate its claims [17]